nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A historic opportunity for universal health coverage in India
|
Patel, Vikram |
|
|
400 |
10351 |
p. 475-477 |
artikel |
2 |
An energy booster for thalassaemic red blood cells
|
Kattamis, Antonis |
|
|
400 |
10351 |
p. 470-471 |
artikel |
3 |
Biologic therapies for asthma in underserved populations
|
Kelly, Rachel S |
|
|
400 |
10351 |
p. 471-473 |
artikel |
4 |
Botswana's HIV/AIDS success
|
Thornton, Jacqui |
|
|
400 |
10351 |
p. 480-481 |
artikel |
5 |
Data at 36 months for the Symplicity SPYRAL HTN-ON MED pilot
|
Snyder, Eric M |
|
|
400 |
10351 |
p. 491-492 |
artikel |
6 |
Data at 36 months for the Symplicity SPYRAL HTN-ON MED pilot – Authors' reply
|
Mahfoud, Felix |
|
|
400 |
10351 |
p. 492 |
artikel |
7 |
Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials
|
Chihara, Dai |
|
|
400 |
10351 |
p. 512-521 |
artikel |
8 |
Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA
|
Mello, Michelle M |
|
|
400 |
10351 |
p. 535-538 |
artikel |
9 |
India at 75 years: progress, challenges, and opportunities
|
The Lancet, |
|
|
400 |
10351 |
p. 469 |
artikel |
10 |
Iran's burden of disease and burden of data collection
|
Maher, Christopher Gerard |
|
|
400 |
10351 |
p. 490 |
artikel |
11 |
Iran's burden of disease and burden of data collection
|
Hashemian, Seyed Mohammadreza |
|
|
400 |
10351 |
p. 490 |
artikel |
12 |
Iran's burden of disease and burden of data collection – Authors' reply
|
Sepanlou, Sadaf G |
|
|
400 |
10351 |
p. 490-491 |
artikel |
13 |
Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial
|
Jackson, Daniel J |
|
|
400 |
10351 |
p. 502-511 |
artikel |
14 |
No clubbing in the fingers, only in the toes: patent ductus arteriosus and reversed shunting
|
Ganesan, Vijayan |
|
|
400 |
10351 |
p. 522 |
artikel |
15 |
Participation in phase 1 trials for patients with cancer
|
Italiano, Antoine |
|
|
400 |
10351 |
p. 473-475 |
artikel |
16 |
Poornima Prabhakaran: advocate for health in a changing climate
|
Prasad, Aarathi |
|
|
400 |
10351 |
p. 484 |
artikel |
17 |
Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study
|
Kuo, Kevin H M |
|
|
400 |
10351 |
p. 493-501 |
artikel |
18 |
Screening policies for cytomegalovirus in pregnancy in the era of antivirals
|
Roberts, Sophie Louise |
|
|
400 |
10351 |
p. 489-490 |
artikel |
19 |
The multispeciality approach to the management of localised kidney cancer
|
Stewart, Grant D |
|
|
400 |
10351 |
p. 523-534 |
artikel |
20 |
The power of Jatra
|
De Ambrogi, Marco |
|
|
400 |
10351 |
p. 487 |
artikel |
21 |
Thomas Bewley
|
Watts, Geoff |
|
|
400 |
10351 |
p. 488 |
artikel |
22 |
Turkish doctors emigrate amid low pay and rising violence
|
Genc, Kaya |
|
|
400 |
10351 |
p. 482-483 |
artikel |
23 |
Use the remaining carbon budget wisely for health equity and climate justice
|
Haines, Andy |
|
|
400 |
10351 |
p. 477-479 |
artikel |
24 |
“You have not remained the same, nor have I”
|
Golwala, Zainab |
|
|
400 |
10351 |
p. 485-486 |
artikel |